[1] GLP-1s have revolutionized weight loss but the sticker shock is real, especially if insurance wont help
Real-world patients may be older, present with multiple comorbidities, receive concomitant medications, and face challenges related to healthcare access, adherence, and long-term disease management
One acts on GHRH receptors
Key Highlights: Supports Fat Metabolism Converts stored fat into usable energy for performance
Short-term effects should be monitored closely, and its crucial to follow the prescribed dosage and guidelines provided by a healthcare professional
Key signaling pathways like PI3K/Akt are not only active within cancer cells but are also pivotal in modulating the TME, for example, by promoting the immunosuppressive activity of CAFs and influencing the behavior of innate immune cells [23, 55]